Alkermes Stock (NASDAQ: ALKS) stock price, news, charts, stock research, profile.
Open | $24.550 |
Close | $24.680 |
Volume / Avg. | 1.017M / 1.988M |
Day Range | 24.300 - 24.800 |
52 Wk Range | 22.010 - 33.710 |
Market Cap | $4.175B |
P/E Ratio | 7.987 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 12.38% |
Days to Cover | 8.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alkermes (NASDAQ: ALKS) through any online brokerage.
Other companies in Alkermes’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Alkermes (NASDAQ: ALKS) was reported by HC Wainwright & Co. on Friday, April 19, 2024. The analyst firm set a price target for 35.00 expecting ALKS to rise to within 12 months (a possible 41.82% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Alkermes (NASDAQ: ALKS) is $24.68 last updated April 26, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Alkermes.
Alkermes’s Q2 earnings are confirmed for Wednesday, July 24, 2024.
There is no upcoming split for Alkermes.
Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.